Found 78 matching trials
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) PHASE4 This is an efficacy and safety study to compare aprepitant with ondansetron...
Show More Location
Multiple Locations
Learn More & Join Trial
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy PHASE2 Chemotherapy induced nausea and vomiting (CINV) is a major adverse effect o...
Show More Location
Princess Margaret Hospital
Learn More & Join Trial
Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer PHASE1 RATIONALE: Antiemetic drugs, such as aprepitant, may help lessen or prevent...
Show More Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Learn More & Join Trial
Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients NA Children aged 2-12 years scheduled to receive moderately or highly emetogen...
Show More Location
Shanghai Children's Medical Center
Learn More & Join Trial
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy PHASE4 Bariatric surgery remains the most effective therapy for obesity. Postopera...
Show More Location
Stony Brook University Hospital
Learn More & Join Trial
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer PHASE2 Cisplatin is one of the most emetogenic drugs used in clinical practice and...
Show More Location
Hallym University Sacred Heart Hospital
Learn More & Join Trial
Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV PHASE3 Chemotherapy-induced nausea and vomiting is a common side effect of cancer ...
Show More Location
Fifth Affilliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Emend for Multiple-day Emetogenic Chemotherapy PHASE2 The purpose of the study is to assess the effect of Emend (aprepitant) on n...
Show More Location
University of Illinois Medical Center
Learn More & Join Trial
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma PHASE1 A proof-of-concept clinical trial assessing the safety of the coordinated u...
Show More Location
University of Ulm School of Medicine
Learn More & Join Trial
Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying PHASE1 This research study is being done to compare the effects of Aprepitant and ...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial